Skip to content

Join our community and subscribe to our free weekly newsletter

Subscribe
  • Latest News
    • Articles
    • Live Talks
    • Trials Update
  • Prevention & Risk Factors
    • Science-Backed Dementia Prevention
    • Alzheimer’s Genetics & Risk Factors
    • Menopause
    • Long COVID
  • Dementias
    • Alzheimer’s Disease
    • Vascular Dementia
    • Frontotemporal Dementia (FTD)
    • Lewy Body Dementia
    • Traumatic Brain Injury & CTE
  • Brain Disorders
    • Mild Cognitive Impairment (MCI)
    • Parkinson’s Disease
  • Getting Diagnosed
    • Diagnosis
    • Journey to Diagnosis
    • Genetic Testing
    • Alzheimer’s Biomarkers
    • Diversity and Dementia
  • Caregivers
    • Caregiver Voices
  • Learning Guides

FAQ - Brain's Immune System

  • Are there other TREM2-targeting Alzheimer’s treatments still in development?

  • Why did the TREM2 drug AL002 cause ARIA side effects in clinical trials?

  • How does AL002 differ from approved Alzheimer’s drugs like Leqembi and Kisunla?

Sign up for our weekly newsletter

Subscribe to get the latest and most trusted brain health science and news, straight to your inbox.

Sign Up

Copyright © 2026 Being Patient. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Join Our Community

Get brain health and dementia news, storytelling, and expert insights right to your inbox. Sign up for our free weekly newsletter.

You're in! Thanks for subscribing — our free weekly newsletter is coming your way.
You’re already subscribed to our newsletter.

About Being Patient

  • Advisors
  • Contribute
  • About Us
  • Partnerships
  • Contact Us
  • Press
  • Glossary

Legal

  • Terms & Conditions
  • Privacy Policy
  • AI Policy
  • Republishing Our Content
Copyright © 2026 Being Patient

Social Media

  • Instagram 
  • Facebook
  • LinkedIn
  • YouTube
  • TikTok
  • X
Copyright © 2026 Being Patient

Page load link
Go to Top